Shandong Molong (00568) will transfer approximately 169 million yuan of debt from Shouguang Baolong to a vegetable wholesale company.
Shandong Molong (00568) announced that the board of directors has agreed for the company to cooperate with Shandong Shouguang Vegetable Wholesale Market Co., Ltd. (hereinafter referred to as "...".
Shandong Molong (00568) announced that the board of directors has approved the company's agreement with Shouguang Vegetable Wholesale Market Co., Ltd. (referred to as "Vegetable Wholesale Company") and Shouguang Baolong Petroleum Equipment Co., Ltd. (referred to as "Shouguang Baolong") to sign a "Tripartite Agreement". According to the agreement, the company will transfer its debt of approximately 169 million yuan to Shouguang Baolong to Vegetable Wholesale Company, and Vegetable Wholesale Company will pay a consideration of 84 million yuan in cash and land and buildings valued at 85.1198 million yuan. After this transaction is completed, Shouguang Baolong will still owe the company about 292 million yuan.
Related Articles

Hubei Guangji Pharmaceutical's subsidiary received the re-registration approval notice for vitamin B6 chemical raw materials.

A-share midday review | Market exploring bottom and rebounding. Technology Innovation 50 Index rose 3.4% to a new high in over 3 years. Semiconductor and computing power industry chains surged.

HK Stock Market Move | Jiangsu Hengrui Pharmaceuticals (01276) rose more than 7% in the morning, reaching a new high in stock prices. Rituximab can beused for a new indication and submitted for listing.
Hubei Guangji Pharmaceutical's subsidiary received the re-registration approval notice for vitamin B6 chemical raw materials.

A-share midday review | Market exploring bottom and rebounding. Technology Innovation 50 Index rose 3.4% to a new high in over 3 years. Semiconductor and computing power industry chains surged.

HK Stock Market Move | Jiangsu Hengrui Pharmaceuticals (01276) rose more than 7% in the morning, reaching a new high in stock prices. Rituximab can beused for a new indication and submitted for listing.
